Brief introduction of Song Lihua enterprises

Anhui anke biotechnology Engineering (Group) Co., Ltd., located in Hefei Hi-tech Industrial Development Zone, is one of the most influential biopharmaceutical enterprises in China. As a leading scientific research enterprise, Anke has always kept pace with foreign biopharmaceutical technology, undertaking more than one national "863" plan, national key torch plan, provincial-level scientific research, major scientific and technological projects and natural fund projects 10, and developing nearly 65,438 national-level new drugs. The leading products such as recombinant human interferon α2b (Andafen) series preparations, recombinant human growth hormone (Anselm) and anti-sperm antibody detection (MAR) kits independently developed by Anke are playing an increasingly important role in the detection and treatment of frequently-occurring and difficult diseases such as hepatitis B, tumor, leukemia growth failure, nutritional support, burns and immune infertility.

Since 2000, Anke Company has successively reorganized the former Anqing Yuliangqing Pharmaceutical Co., Ltd. and Tongling No.1 Pharmaceutical Factory, and established Anke Yuliangqing Pharmaceutical Co., Ltd., Anke Hengyi Pharmaceutical Co., Ltd. and Anke Xinxing Pharmaceutical Co., Ltd., and the product range has expanded from biopharmaceuticals to modern Chinese medicine and chemically synthesized drugs. The sales network covers 30 provinces, municipalities and autonomous regions in China, and some products have entered the international market.

Anke people will provide safer and more effective medical products for the society with more professional services to meet people's growing health needs.